|

China Monogenic Diabetes Registry

RECRUITINGSponsored by Tianjin Medical University General Hospital
Actively Recruiting
SponsorTianjin Medical University General Hospital
Started2021-02-28
Est. completion2030-07-31
Eligibility
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT07492004

Summary

This observational study aims to establish a digital registry, screening platform for patients with monogenic diabetes using internet-based and mobile application technologies. The primary objectives are to: Characterize the genetic landscape of monogenic diabetes in the Chinese population, including pathogenic variants and their distribution Participants will: * Enroll in the monogenic diabetes registry via mobile application or web-based platform * Undergo molecular genetic testing to establish a definitive diagnosis

Eligibility

Healthy volunteers accepted
Inclusion Criteria:

1. Diabetes diagnosed before 25 years of age; OR diabetes diagnosed before 35 years of age with ≥1 first-degree relative (parent, sibling, or offspring) diagnosed with diabetes before 40 years of age
2. Body mass index (BMI) at diagnosis 28 kg/m²
3. Negative glutamic acid decarboxylase antibody (GAD-Ab)

Exclusion Criteria:

1. Secondary diabetes
2. Active malignancy or history of malignant tumor within the past 5 years

Conditions4

DiabetesMaturity Onset Diabetes of the YoungMonogenic DiabetesNeonatal Diabetes

Browse More Trials

Diabetes trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.